pleconaril has been researched along with Neonatal Early-Onset Sepsis in 2 studies
WIN 63843: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abzug, MJ | 1 |
| Michaels, MG | 1 |
| Wald, E | 1 |
| Jacobs, RF | 1 |
| Romero, JR | 1 |
| Sánchez, PJ | 1 |
| Wilson, G | 1 |
| Krogstad, P | 1 |
| Storch, GA | 1 |
| Lawrence, R | 1 |
| Shelton, M | 1 |
| Palmer, A | 1 |
| Robinson, J | 1 |
| Dennehy, P | 1 |
| Sood, SK | 1 |
| Cloud, G | 1 |
| Jester, P | 1 |
| Acosta, EP | 1 |
| Whitley, R | 1 |
| Kimberlin, D | 1 |
| Hernández, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 1 Study to Confirm the Single- and Multiple-dose Pharmacokinetics and to Evaluate Food Effect of Vapendavir in Healthy Participants and Participants With COPD[NCT05962645] | Phase 1 | 24 participants (Anticipated) | Interventional | 2023-05-19 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for pleconaril and Neonatal Early-Onset Sepsis
| Article | Year |
|---|---|
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.
Topics: Antiviral Agents; Double-Blind Method; Enterovirus; Enterovirus Infections; Female; Humans; Infant; | 2016 |
[A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis].
Topics: Antiviral Agents; Double-Blind Method; Enterovirus Infections; Female; Humans; Infant, Newborn; Male | 2016 |